Production (Stage)
The Clorox Company
CLX
$130.88
-$0.02-0.02%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.02B | 7.17B | 7.47B | 7.09B | 7.21B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.02B | 7.17B | 7.47B | 7.09B | 7.21B |
| Cost of Revenue | 3.86B | 3.98B | 4.14B | 4.03B | 4.16B |
| Gross Profit | 3.16B | 3.19B | 3.33B | 3.07B | 3.05B |
| SG&A Expenses | 1.81B | 1.84B | 1.86B | 1.81B | 1.98B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 189.00M | 196.00M | 201.00M | 222.00M | 40.00M |
| Total Operating Expenses | 5.97B | 6.14B | 6.33B | 6.19B | 6.31B |
| Operating Income | 1.05B | 1.03B | 1.14B | 904.00M | 898.00M |
| Income Before Tax | 943.00M | 647.00M | 546.00M | 398.00M | 360.00M |
| Income Tax Expenses | 234.00M | 179.00M | 176.00M | 106.00M | 108.00M |
| Earnings from Continuing Operations | 709.00 | 468.00 | 370.00 | 292.00 | 252.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -11.00M | -13.00M | -12.00M | -12.00M |
| Net Income | 694.00M | 457.00M | 357.00M | 280.00M | 240.00M |
| EBIT | 1.05B | 1.03B | 1.14B | 904.00M | 898.00M |
| EBITDA | 1.26B | 1.24B | 1.35B | 1.13B | 1.13B |
| EPS Basic | 5.60 | 3.69 | 2.88 | 2.25 | 1.94 |
| Normalized Basic EPS | 4.75 | 4.71 | 5.16 | 4.00 | 3.97 |
| EPS Diluted | 5.57 | 3.66 | 2.87 | 2.24 | 1.92 |
| Normalized Diluted EPS | 4.72 | 4.68 | 5.14 | 3.99 | 3.95 |
| Average Basic Shares Outstanding | 495.23M | 496.11M | 496.52M | 496.70M | 496.22M |
| Average Diluted Shares Outstanding | 498.46M | 498.64M | 498.60M | 498.57M | 498.16M |
| Dividend Per Share | 4.88 | 4.86 | 4.84 | 4.82 | 4.80 |
| Payout Ratio | 86.60% | 131.07% | 167.23% | 212.50% | 246.67% |